CD4 and Sepsis: In this regard, Chang et al. showed that use of AMSCEXOcan effectively inhibit systemic inflammation induced by sepsis in rats, by increasing the number of circulating and splenic Tregs, while decreases the number of CD3+/CD4+ and CD3+/CD8+ cells, thus having a significant protective effect on brain injury induced by sepsis (10).